This association between increased levels of FHR1 and reduced kidney function is evident not only in IgA nephropathy but also in patients with CKD secondary to autosomal dominant polycystic kidney disease, a noncomplement-mediated kidney disease, suggesting that reduced kidney function increases FHR1 plasma levels (64). This evidence concerns the gene CFHR1 and chronic kidney disease.